Cephalopods in neuroscience: regulations, research and the 3Rs
Graziano Fiorito(University of Calabria), Paul Andrews(St George's, University of London), Michael J. Kuba(Federico II University Hospital), Giovanna Ponte(Stazione Zoologica Anton Dohrn), Felix Christopher Mark(Alfred-Wegener-Institut Helmholtz-Zentrum für Polar- und Meeresforschung), David Anderson(The University of Sydney), António V. Sykes(University of Algarve), Daniel Osorio(University of Sussex), Roger Villanueva(Institut Català de Ciències del Clima), Fulvio Maffucci(Stazione Zoologica Anton Dohrn), Arianna Manciocco(Institute of Cognitive Sciences and Technologies), Camino Gestal(Instituto de Investigacións Mariñas), Andrea Affuso(Stazione Zoologica Anton Dohrn), Marcello Raspa(National Research Council), Alison G. Cole(University of Vienna), Nadav Shashar(Ben-Gurion University of the Negev), Ludovic Dickel(Centre National de la Recherche Scientifique), Rute R. da Fonseca(University of Copenhagen), Paolo de Girolamo(University of Naples Federico II), Ngaire Dennison(Home Office), Daniela Melillo(Stazione Zoologica Anton Dohrn), Tore Kristiansen(Norwegian Institute of Marine Research), Giovanni Botta(Ministero della Salute), Kerry Perkins(University of Sussex), Livia D’Angelo(University of Naples Federico II), Anna Di Cosmo(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli), Laure Bonnaud(Centre National de la Recherche Scientifique), David Smith(Loughborough University), Jane A. Smith(Boyds (United Kingdom)), Frank W. Grasso(Brooklyn College), Carlo Di Cristo(University of Sannio), Nathan J. Tublitz(University of Oregon), Anna Palumbo(Ospedale San Paolo), Jennifer Basil(The Graduate Center, CUNY), Letizia Zullo(Italian Institute of Technology)
Cited by 165
Related Papers
Proteomic Analysis of a Pleistocene Mammoth Femur Reveals More than One Hundred Ancient Bone Proteins
|Journal of Proteome Research|2011|241
Mechanism of inhibition of melanogenesis by hydroquinone
|Biochimica et Biophysica Acta (BBA) - General Subjects|1991|241
Biomanufacturing for clinically advanced cell therapies
|Nature Biomedical Engineering|2018|191